PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
19-Jun-2025 Alfa Chemistry Reorganizes Pheromone Chemicals Based on Carbon Number (Main Chain) Alfa Chemistry
18-Jun-2025 Meteor Biotech selected to deliver keynote talk at Hong Kong International Oncology Forum 2025 (HKIOF) Andrew Lloyd Associates
17-Jun-2025 Avata Biosciences Signs Co-Development and Licensing Agreement with Oceanus Bio for Exclusive Rights in Japan and Asia (Excluding China and India) for Novel Adult and Pediatric Oral Cannabidiol Therapies for Development in Epilepsy and Schizophrenia Avata Biosciences Holdings Ltd
17-Jun-2025 Astoriom Appoints Brittany Jackson as CFO Astoriom
17-Jun-2025 Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients Captain T Cell
16-Jun-2025 Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA Veranova
16-Jun-2025 Alfa Chemistry Expands Its Portfolio with the Release of Dozens of Pyrrole Alkaloids Alfa Chemistry
16-Jun-2025 Alfa Chemistry Expands Portfolio with High-Quality Ion Exchange Resins and Chromatography Media for Enhanced Purification and Separation Alfa Chemistry
14-Jun-2025 Jetbio rolls out miniReJI 3D Bioprinters for printing of cancer cell models Jetbio Ltd
13-Jun-2025 Datalogic and B. Braun enable safer oncology treatment with Memor™ 17 Healthcare Certification for OncoSafety Remote Control® datalogic
12-Jun-2025 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity UCB
12-Jun-2025 Accelerate@Babraham 2025 announces new cohort Babraham
12-Jun-2025 AlzeCure receives positive FDA response regarding Phase II/III studies with ACD440 in a rare disease AlzeCure
12-Jun-2025 Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison Johnson & Johnson
12-Jun-2025 Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR Levicept
12-Jun-2025 Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma Enterome
12-Jun-2025 AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors AstriVax Therapeutics
12-Jun-2025 Oxeltis and Molecular Forecaster forge strategic collaboration to enhance client’s drug design and synthesis Andrew Lloyd Associates
11-Jun-2025 Biomunex Pharmaceuticals appoints its new Scientific Advisory Board on MAIT, composed of MAIT cell experts to accelerate the development of its MAIT engagers in immuno-oncology Biomunex Pharmaceuticals
11-Jun-2025 Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD Outlook Therapeutics